Pitavastatin CAS: 147511-69-1 Chaw Tsim Khoom

Pitavastatin yog ib qho tshuaj inhibitor ntawm HMG-CoA reductase uas ua rau thawj kauj ruam ntawm kev tsim cov roj cholesterol. Nws zoo li tsis muaj ntxhiab thiab dawb mus rau daj ntseg hmoov. Nws ua haujlwm los ntawm kev txo cov roj cholesterol hauv lub cev. Yog li ntawd, nws feem ntau yog siv rau kev kho mob hypercholesterolaemia thiab kev tiv thaiv kab mob plawv. Nws tsis tsuas yog txo cov roj cholesterol thiab triglyceride hauv qee tus neeg mob xwb, tab sis kuj tseem tuaj yeem ua rau cov roj cholesterol ntau (HDL), uas yog cov roj cholesterol "zoo". Feem ntau nws yuav tsum tau noj ua ke nrog kev noj zaub mov kom zoo.

Txiav txim los yog Thov Kev Hais Nqe

Cov Khoom Qhia Txog Khoom

Cov Cim Npe Khoom

Daim Ntawv Thov thiab Cov Nyhuv

Pivastatin yog ib yam tshuaj tiv thaiv kab mob hyperlipidemic. Nws tsis yog tsuas yog ib yam tshuaj statin tshiab, ua haujlwm tau zoo, muaj kev nyab xeeb, thiab tshuaj synthesized lipid-lowering uas muaj txiaj ntsig zoo tshaj plaws, tab sis kuj yog ib qho inhibitor muaj zog ntawm 3-hydroxy-3-methylglutaryl CoA (HMG-CoA reductase) reductase. Nws tsis yog tsuas yog muaj txiaj ntsig zoo rau kev txo LDL-C thiab TC, tab sis kuj muaj cov qauv genetic polymorphism, bioavailability siab, thiab lub neej ntev. Tsuas yog ob peb tus neeg tau txais CYP2C9 metabolism. Siv los kho thawj hyperlipidemia, tsev neeg hypercholesterolemia, thiab cov teeb meem lipid sib xyaw.

Qauv Khoom

Khoom Ntim:

Cov Lus Qhia Ntxiv:

Kev sau ua ke	C25H24FNO4
Kev Ntsuas	99%
Qhov tsos	Dawb rau Off-White hmoov
CAS Nr.	147511-69-1
Ntim khoom	25KG
Lub Neej Txee	2 xyoos
Kev Khaws Cia	Khaws cia rau qhov chaw txias thiab qhuav
Daim Ntawv Pov Thawj	ISO.